Increased basal phosphorylation of the constitutively active serotonin 2C receptor accompanies agonist-mediated desensitization

RS Westphal, JR Backstrom and E Sanders-Bush

Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA.

The 5-hydroxytryptamine (5-HT)2C receptor is a G protein-coupled receptor that exhibits constitutive receptor activation, defined as agonist-independent receptor activation of the signal transduction pathway. The present studies were performed to determine whether NIH/3T3 fibroblasts expressing the 5-HT2C receptor exhibited desensitization of agonist-mediated phosphoinositide hydrolysis. Furthermore, 5-HT2C receptor-specific antibodies were used to determine whether the 5-HT2C receptor was phosphorylated in the absence of agonist and whether treatment with an agonist or an inverse agonist altered receptor phosphorylation. Time course studies of basal and serotonin-stimulated phosphoinositide hydrolysis demonstrated that basal values increased in a linear manner, whereas the response to serotonin plateaued within 60 min. In addition, pretreatment with serotonin resulted in a rightward shift of the subsequently determined serotonin dose-response curve. To determine the phosphorylation state of the 5-HT2C receptor, specific antibodies were used to immunoprecipitate the receptor from lysates prepared from 32P-labeled fibroblasts. Phosphorylation of the 5-HT2C receptor was evident under basal conditions, and serotonin treatment increased receptor phosphorylation. The inverse agonist mianserin had no detectable effect on 5-HT2C receptor phosphorylation when added alone but blocked the serotonin-stimulated increase in 5-HT2C receptor phosphorylation. The present study is the first to demonstrate that the 5-HT2C receptor is phosphorylated under basal conditions and phosphorylation is increased by agonist treatment conditions that result in desensitization of receptor signaling. Thus, these studies demonstrate that a cell line exhibiting a high level of constitutive 5-HT2C receptor activity has the ability to undergo agonist-mediated desensitization, consistent with current models of G protein-coupled receptor regulation.

Volume 48, Issue 2, pp. 200-205, 08/01/1995
Copyright © 1995 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				K. A. Berg, S. Navailles, T. A. Sanchez, Y. M. Silva, M. D. Wood, U. Spampinato, and W. P. Clarke J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 260 - 268. [Abstract] [Full Text] [PDF]

				S. Marion, D. M. Weiner, and M. G. Caron RNA Editing Induces Variation in Desensitization and Trafficking of 5-Hydroxytryptamine 2c Receptor Isoforms J. Biol. Chem., January 23, 2004; 279(4): 2945 - 2954. [Abstract] [Full Text] [PDF]

				L. L. Parker, J. R. Backstrom, E. Sanders-Bush, and B.-H. Shieh Agonist-induced Phosphorylation of the Serotonin 5-HT2C Receptor Regulates Its Interaction with Multiple PDZ Protein 1 J. Biol. Chem., June 6, 2003; 278(24): 21576 - 21583. [Abstract] [Full Text] [PDF]

				C. Prioleau, I. Visiers, B. J. Ebersole, H. Weinstein, and S. C. Sealfon Conserved Helix 7 Tyrosine Acts as a Multistate Conformational Switch in the 5HT2C Receptor. IDENTIFICATION OF A NOVEL "LOCKED-ON" PHENOTYPE AND DOUBLE REVERTANT MUTATIONS J. Biol. Chem., September 20, 2002; 277(39): 36577 - 36584. [Abstract] [Full Text] [PDF]

				B. D. Stout, W. P. Clarke, and K. A. Berg Rapid Desensitization of the Serotonin2C Receptor System: Effector Pathway and Agonist Dependence J. Pharmacol. Exp. Ther., September 1, 2002; 302(3): 957 - 962. [Abstract] [Full Text] [PDF]

				Y. Sun and M. C. Gershengorn Correlation between Basal Signaling and Internalization of Thyrotropin-Releasing Hormone Receptors: Evidence for Involvement of Similar Receptor Conformations Endocrinology, August 1, 2002; 143(8): 2886 - 2892. [Abstract] [Full Text] [PDF]

				W.-b. Zhang, J.-M. Navenot, B. Haribabu, H. Tamamura, K. Hiramatu, A. Omagari, G. Pei, J. P. Manfredi, N. Fujii, J. R. Broach, et al. A Point Mutation That Confers Constitutive Activity to CXCR4 Reveals That T140 Is an Inverse Agonist and That AMD3100 and ALX40-4C Are Weak Partial Agonists J. Biol. Chem., June 28, 2002; 277(27): 24515 - 24521. [Abstract] [Full Text] [PDF]

				T. KENAKIN Inverse, protean, and ligand-selective agonism: matters of receptor conformation FASEB J, March 1, 2001; 15(3): 598 - 611. [Abstract] [Full Text] [PDF]

				W. G. Thomas, H. Qian, C.-S. Chang, and S. Karnik Agonist-induced Phosphorylation of the Angiotensin II (AT1A) Receptor Requires Generation of a Conformation That Is Distinct from the Inositol Phosphate-signaling State J. Biol. Chem., January 28, 2000; 275(4): 2893 - 2900. [Abstract] [Full Text] [PDF]

				K.-S. Min, X. Liu, J. Fabritz, J. Jaquette, A. N. Abell, and M. Ascoli Mutations That Induce Constitutive Activation and Mutations That Impair Signal Transduction Modulate the Basal and/or Agonist-stimulated Internalization of the Lutropin/Choriogonadotropin Receptor J. Biol. Chem., December 25, 1998; 273(52): 34911 - 34919. [Abstract] [Full Text] [PDF]

				J. R. Backstrom, R. D. Price, D. T. Reasoner, and E. Sanders-Bush Deletion of the Serotonin 5-HT2C Receptor PDZ Recognition Motif Prevents Receptor Phosphorylation and Delays Resensitization of Receptor Responses J. Biol. Chem., July 28, 2000; 275(31): 23620 - 23626. [Abstract] [Full Text] [PDF]